Cargando…
Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance
OBJECTIVE: Paraganglioma (PGL) and pheochromocytoma (PCC) are rare neuroendocrine tumors that were considered to be predominantly sporadic. However, with the identification of novel susceptibility genes over the last decade, it is currently estimated that up to 40% of cases can occur in the context...
Autores principales: | Gómez, Ana Milena, Soares, Diogo Cordeiro, Costa, Alexandre André Balieiro, Pereira, Daniele Paixão, Achatz, Maria Isabel, Formiga, Maria Nirvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528659/ https://www.ncbi.nlm.nih.gov/pubmed/31365623 http://dx.doi.org/10.20945/2359-3997000000145 |
Ejemplares similares
-
Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
por: Turin, Christie G, et al.
Publicado: (2022) -
Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
por: Huang, Yiqiang, et al.
Publicado: (2018) -
SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas
por: Manotas, María Carolina, et al.
Publicado: (2023) -
Pathogenicity and Penetrance of Germline SDHA Variants in Pheochromocytoma and Paraganglioma (PPGL)
por: Maniam, Pavithran, et al.
Publicado: (2018) -
Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
por: Vanova, Katerina Hadrava, et al.
Publicado: (2021)